179 related articles for article (PubMed ID: 35149993)
1. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India.
Parida SP; Sahu DP; Singh AK; Alekhya G; Subba SH; Mishra A; Padhy BM; Patro BK
J Med Virol; 2022 Jun; 94(6):2453-2459. PubMed ID: 35149993
[TBL] [Abstract][Full Text] [Related]
2. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
Puspitarani F; Sitaresmi MN; Ahmad RA
Front Public Health; 2022; 10():999354. PubMed ID: 36388348
[TBL] [Abstract][Full Text] [Related]
3. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
Rahmat H; Leelavathi M; Wan Ismail WF
Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia.
Supangat ; Sakinah EN; Nugraha MY; Qodar TS; Mulyono BW; Tohari AI
BMC Pharmacol Toxicol; 2021 Oct; 22(1):58. PubMed ID: 34641944
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis.
Kaur U; K L A; Chauhan M; Joshi A; Das A; Kansal S; Jaisawal V; Patwardhan K; Chakrabarti SS
Drug Saf; 2022 Oct; 45(10):1099-1109. PubMed ID: 36030299
[TBL] [Abstract][Full Text] [Related]
6. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
Choi YY; Kim MK; Kwon HC; Kim GH
J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
[TBL] [Abstract][Full Text] [Related]
8. Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.
Jose M; Rajmohan P; Thomas J; Krishna S; Antony B; Gopinathan UU; Iyyapan EM; Porinchu RM; Jose P; Raphael L; Kuttichira P
Curr Drug Saf; 2022; 17(4):327-334. PubMed ID: 35135453
[TBL] [Abstract][Full Text] [Related]
9. Stimulated Reporting of Adverse Events Following Immunization with COVID-19 Vaccines.
Jhaj R; Chaudhary D; Shukla AK; Yadav J
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560545
[TBL] [Abstract][Full Text] [Related]
10. To Study Adverse Effect following Immunization (AEFI) and COVID-19 Infection amongst COVID-19 Vaccine Benefeciaries.
N PP; S CS; F JV; B AB; A KM; T DP; N GC; R IA
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436817
[TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
Rayamajhi S; Rafi MA; Tripathi N; Dongol AS; Pandey M; Rayamajhi S; Bhandari S; Shrestha P; Hasan MT; Hossain MG
PLoS One; 2022; 17(8):e0272729. PubMed ID: 35947626
[TBL] [Abstract][Full Text] [Related]
12. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
Chakraborty A; Reval N; Kamath L
Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
[TBL] [Abstract][Full Text] [Related]
13. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
Kant A; Jansen J; van Balveren L; van Hunsel F
Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
[TBL] [Abstract][Full Text] [Related]
14. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
15. Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana.
Marfoh K; Samba A; Okyere E; Acheampong F; Owusu E; Darko DNA; Zakariah J; Mensa H; Aidoo E; Mohammed Y
BMJ Open; 2023 Jun; 13(6):e061643. PubMed ID: 37380201
[TBL] [Abstract][Full Text] [Related]
16. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System.
Jeon M; Kim J; Oh CE; Lee JY
J Korean Med Sci; 2021 May; 36(17):e114. PubMed ID: 33942578
[TBL] [Abstract][Full Text] [Related]
17. Safety and adverse events following COVID-19 vaccination among people with epilepsy: A cross-sectional study.
Ong MJY; Khoo CS; Lee YX; Poongkuntran V; Tang CK; Choong YJ; Hod R; Tan HJ
Epilepsia Open; 2023 Mar; 8(1):60-76. PubMed ID: 36214033
[TBL] [Abstract][Full Text] [Related]
18. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
Christou-Ergos M; Wiley KE; Leask J
Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
[TBL] [Abstract][Full Text] [Related]
19. Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.
Bwire G; Kisakye A; Amulen E; Bwanika JB; Badebye J; Aanyu C; Nakirya BD; Okello A; Okello SA; Bukenya JN; Orach CG
BMC Infect Dis; 2023 Jul; 23(1):487. PubMed ID: 37479986
[TBL] [Abstract][Full Text] [Related]
20. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
